Literature DB >> 30309270

Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens?

Gabriel Lima-Oliveira1,2, Denis Monneret3, Fabrice Guerber4, Gian Cesare Guidi1,2.   

Abstract

The constrained economic context leads laboratories to centralize their routine analyses on high-throughput platforms, to which blood collection tubes are sent from peripheral sampling sites that are sometimes distantly located. Providing biochemistry results as quickly as possible implies to consolidate the maximum number of tests on a minimum number of blood collection tubes, mainly serum tubes and/or tubes with anticoagulants. However, depending on the parameters and their pre-analytical conditions, the type of matrix - serum or plasma - may have a significant impact on results, which is often unknown or underestimated in clinical practice. Importantly, the matrix-related effects may be a limit to the consolidation of analyses on a single tube, and thus must be known by laboratory professionals. The purpose of the present critical review is to put forward the main differences between using serum and plasma samples on clinical biochemistry analyses, in order to sensitize laboratory managers to the need for standardization. To enrich the debate, we also provide an additional comparison of serum and plasma concentrations for approximately 30 biochemistry parameters. Properties, advantages, and disadvantages of serum and plasma are discussed from a pre-analytical standpoint - before, during, and after centrifugation - with an emphasis on the importance of temperature, delay, and transport conditions. Then, differences in results between these matrices are addressed for many classes of biochemistry markers, particularly proteins, enzymes, electrolytes, lipids, circulating nucleic acids, metabolomics markers, and therapeutic drugs. Finally, important key-points are proposed to help others choose the best sample matrix and guarantee quality of clinical biochemistry assays. Moreover, awareness of the implications of using serum and plasma samples on various parameters assayed in the laboratory is an important requirement to ensure reliable results and improve patient care.

Entities:  

Keywords:  Serum; biochemistry; blood specimen collection; clinical laboratory techniques; patient safety; plasma; preanalytical phase; sample matrix; total quality management

Mesh:

Year:  2018        PMID: 30309270     DOI: 10.1080/10408363.2018.1499708

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  9 in total

1.  Pathologic Blood Samples Tolerate Exposure to Vibration and High Turbulence in Simulated Drone Flights, but Plasma Samples Should be Centrifuged After Flight.

Authors:  Karl Arne Johannessen; Nina Kristin Steen Wear; Karin Toska; Morten Hansbo; Jens Petter Berg; Erik Fosse
Journal:  IEEE J Transl Eng Health Med       Date:  2021-01-20       Impact factor: 3.316

2.  Agreement of Potassium, Sodium, Glucose, and Hemoglobin Measured by Blood Gas Analyzer With Dry Chemistry Analyzer and Complete Blood Count Analyzer: A Two-Center Retrospective Analysis.

Authors:  Hongxiang Xie; Shiyu Lv; Sufeng Chen; Zhenzhen Pang; Deli Ye; Jianzhuang Guo; Wanju Xu; Weidong Jin
Journal:  Front Med (Lausanne)       Date:  2022-04-01

3.  Impact of an Andean breakfast on biochemistry and immunochemistry laboratory tests: an evaluation on behalf COLABIOCLI WG-PRE-LATAM.

Authors:  Wilson Bajaña; Eduardo Aranda; Maria Elena Arredondo; Lorena Michele Brennan-Bourdon; Marise Danielle Campelo; Edgar Espinoza; Silvia Flores; Patricia Ochoa; Veronica Vega; Beatriz Varela; Gabriel Lima-Oliveira
Journal:  Biochem Med (Zagreb)       Date:  2019-04-15       Impact factor: 2.313

4.  Sample Management: Stability of Plasma and Serum on Different Storage Conditions.

Authors:  Carlos Fernando Yauli Flores; Ángela de Las Mercedes Hurtado Pineda; Victoria Maritza Cevallos Bonilla; Klever Sáenz-Flor
Journal:  EJIFCC       Date:  2020-03-20

5.  Rejection of hemolyzed samples can jeopardize patient safety.

Authors:  Lorenzo Barbato; Marise Danielle Campelo; Sara Pigozzo; Nicola Realdon; Anna Gandini; Roberto Barbazza; Mayara Ladeira Coêlho; Chiara Bovo; Paola Marini; Gabriel Lima-Oliveira
Journal:  EJIFCC       Date:  2020-03-20

6.  A comparison of stability of chemical analytes in plasma from the BD Vacutainer® Barricor™ tube with mechanical separator versus tubes containing gel separator.

Authors:  Ghassaan Gawria; Linda Tillmar; Eva Landberg
Journal:  J Clin Lab Anal       Date:  2019-10-11       Impact factor: 2.352

7.  D-dimer in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis.

Authors:  Guangxu Lu; Tong Li; Haoqi Ye; Shujin Liu; Peng Zhang; Wenliang Wang
Journal:  J Orthop Surg Res       Date:  2020-07-16       Impact factor: 2.359

8.  Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.

Authors:  Meenu Rohini Rajan; Matus Sotak; Fredrik Barrenäs; Tong Shen; Kamil Borkowski; Nicholas J Ashton; Christina Biörserud; Tomas L Lindahl; Sofia Ramström; Michael Schöll; Per Lindahl; Oliver Fiehn; John W Newman; Rosie Perkins; Ville Wallenius; Stephan Lange; Emma Börgeson
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

Review 9.  Defining Blood Plasma and Serum Metabolome by GC-MS.

Authors:  Olga Kiseleva; Ilya Kurbatov; Ekaterina Ilgisonis; Ekaterina Poverennaya
Journal:  Metabolites       Date:  2021-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.